The risk of HBV reactivation by HCV patients undergoing DAA treatment
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000025871
- Lead Sponsor
- Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included (1) decompensated cirrhosis with Child-Pugh B or C, (2) prior experience of anti-HBV treatment with IFN or nucleos(t)ide analogue, and (3) under treatment with immunosuppressive agents or chemotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method